Eritoran could not protect diabetic mice administered LPS from deterioration in the general condition but eritroan may induce remission of nephropathy by protecting glomeruli from TLR4 ligands which are derived from the destroyed bacteria in the intestine or lung under the septic-like state caused by the long term immunization of Pg-LPS. Here, TLR4 is linked to kidney disorder.